Our Pipeline
Our pipeline leverages on our modular core technology to target tumor using enhanced CAR-T cells.
| Product | Target | Enhancements | Preclinical | IND | Phase I | Phase II | Phase III | Next Milestone |
|---|---|---|---|---|---|---|---|---|
| TAVST01 | B7-H3 |
Engineered SerpinB9 -- SB9(CAS) -- |
IND in Preparation
|
IND Submission | ||||
| TAVST02 | To be disclosed | To be disclosed |
|
Complete Preclinical | ||||
| TAVST03 | To be disclosed | To be disclosed |
|
Proof of Concept | ||||